LEADER 01482nam  2200349   450 
001 9910678588603321
005 20230502061438.0
010   $a1-80356-126-2
035   $a(CKB)5840000000237840
035   $a(NjHacI)995840000000237840
035   $a(EXLCZ)995840000000237840
100   $a20230502d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPharmacovigilance$hVolume 2 /$fCharmy S. Kothari, editor
210  1$aLondon :$cIntechOpen,$d2023.
215   $a1 online resource (124 pages)
311   $a1-80356-125-4 
330   $aThis book discusses various topics in pharmacovigilance. The first section addresses such topics as approaches to minimize adverse drug reactions, different stakeholders and their importance in pharmaceutical policy development, changing needs for pharmacovigilance in the African region, machine learning applications in pharmacovigilance, and pharmacovigilance of biological drugs. The second section discusses signal detection, which is a promising approach that helps in the early identification of new, rare drug reactions (desired or undesired).
606   $aDrug monitoring
615  0$aDrug monitoring.
676   $a615.7 
702   $aKothari$b Charmy S.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910678588603321
996   $aPharmacovigilance$91541941
997   $aUNINA